Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign recurrent intrahepatic cholestasis.

V A Luketic1, M L Shiffman

  • 1Department of Medicine, Hepatology Section, Medical College of Virginia Commonwealth University, Richmond, Virginia, USA.

Clinics in Liver Disease
|April 9, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2015
Same author

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.

Journal of viral hepatitis·2013
Same author

Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin.

Journal of viral hepatitis·2012
Same author

Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.

Genes and immunity·2012
Same author

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.

Alimentary pharmacology & therapeutics·2010
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Benign recurrent intrahepatic cholestasis is a rare genetic liver disorder causing intense itching and jaundice. This condition, linked to chromosome 18, involves a P-type ATPase defect but does not cause progressive liver damage.

Area of Science:

  • Hepatology
  • Genetics
  • Biochemistry

Background:

  • Benign recurrent intrahepatic cholestasis (BRIC) is a rare genetic disorder.
  • It presents with recurrent episodes of cholestasis, characterized by intense pruritus and jaundice.
  • Patients experience symptom-free intervals between attacks, and the condition does not lead to progressive liver disease.

Purpose of the Study:

  • To summarize the key features of benign recurrent intrahepatic cholestasis.
  • To highlight the genetic basis and biochemical defect associated with the disorder.
  • To outline current therapeutic approaches for managing symptomatic periods.

Main Methods:

  • Review of clinical and genetic studies on benign recurrent intrahepatic cholestasis.
  • Analysis of the genetic mapping to chromosome 18.

Related Experiment Videos

  • Identification of the implicated gene encoding a P-type ATPase.

    • Main Results:

    • BRIC is an autosomal recessive disorder.
    • Genetic defect localized to chromosome 18, involving a P-type ATPase gene.
    • The P-type ATPase is implicated in aminophospholipid transport.

    Conclusions:

    • Benign recurrent intrahepatic cholestasis is a distinct genetic disorder affecting bile transport.
    • Understanding the genetic defect provides insight into its pathophysiology.
    • Management focuses on symptomatic relief during cholestatic episodes.